shenzhen salubris pharmaceuticals co., ltd.-凯发k8旗舰厅app

news & trends

• 102023-10

  new overseas clinical progress of jk07 for the treatment of chronic heart failure (hfref)

• 082023-10

  sal0120 tablets for treatment of iga nephropathy approved for clinical trial

• 102023-08

  vena cava filter system (saexten®) approved by nmpa

• 092023-06

  enarodustat（恩那罗®） approved by nmpa for treatment of renal anemia (abstract) nmpa approved enarodustat（恩那罗®）

• 052023-02

  the clinical progress of sal0119 tablets for the treatment of ankylosing spondylitis and rheumatoid arthritis

• 182023-01

  progress of s086 for the treatment of mild to moderate primary hypertension